Pfizer CEO Albert Bourla appeared on CNBC’s “Squawk Box,” where he explained that oral drugs for COVID-19 could be available next year.
Bourla told the CNBC host, “If all goes well, and we implement the same speed that we are, and if regulators do the same, and they are, I hope that by the end of the year.”
Bourla said Pfizer is working on two antivirals, an oral and an injectable.
— Squawk Box (@SquawkCNBC) April 27, 2021
Bourla explained, “Particular attention is on the oral because it provides several advantages. One of them is that you don’t need to go to the hospital to get the treatment, which is the case with all the injectables so far. You could get it at home, and that could be